Brokers and intermediaries placing business with South Korean life insurers face growing counterparty risk as capital shortfalls under the country’s solvency regime stall M&A transactions and expose weaknesses in insurer balance sheets.
The latest case is KDB Life Insurance. Korea Development Bank (KDB) and Korea Investment Holdings remain unable to agree on how much capital the insurer needs before the proposed sale can close, according to Chosun Business. KDB named Korea Investment Holdings as the preferred bidder on August 13, 2026, and a stock purchase agreement was expected by the end of September. More than two months later, the deal is unsigned.
This is the seventh attempt to sell KDB Life since 2014, with six previous efforts having collapsed. For intermediaries monitoring counterparty stability, repeated failed sales of an undercapitalised insurer represent an ongoing source of uncertainty around policy continuity and claims-paying ability.
Read next: KDB Life’s seventh sale attempt is a broker counterparty story
The dispute centres on the size of the pre-acquisition capital injection. Korea Investment Holdings has requested 1 trillion won, while KDB, which has already committed approximately 2 trillion won to the insurer, is resistant to further outlay. KDB Life held total assets of 16.6 trillion won as of mid-2026, according to The Korea Times.
The demand reflects KDB Life’s position under the Korean Insurance Capital Standard (K-ICS), the risk-based solvency regime that Skadden, Arps, Slate, Meagher & Flom LLP described in an April 2026 publication as “the cornerstone of South Korea’s prudential regime.”
As of the end of June 2026, KDB Life’s solvency ratio before transitional measures stood at 78.7%, according to Chosun Business. That is well below the 130% level that South Korea’s Financial Supervisory Service (FSS) expects insurers to maintain. With transitional measures applied, the ratio rises to 182.4%, but the underlying shortfall remains.
At the core capital level, the gap is starker. KDB Life’s core capital solvency ratio before transitional measures was minus 26.1%. Even with a 1 trillion won injection, that ratio would rise to only about 38%. An additional 180 billion won would still be needed to reach the 50% regulatory threshold that South Korea’s Financial Services Commission (FSC) plans to enforce from 2027.
KDB covered about 504 billion won of a 515 billion won rights issue at the end of 2025 and is expected to inject a further 300 billion to 500 billion won this year. If the policy bank strengthens the balance sheet but cannot recover the cost from the sale proceeds, it would effectively be absorbing the buyer’s future capital obligations.
“While the odds favour completing the acquisition, Korea Investment & Securities Co. holds the upper hand in the negotiations,” an investment banking industry source told Chosun Business.
Read more: Bond market collapse exposes a two-tier Korean insurance sector
KDB Life is not an isolated case. As of the end of June 2026, six Korean insurers reported core capital solvency ratios below the incoming 50% minimum, according to FSS data reported by the Seoul Economic Daily. Among life insurers, KDB Life reported 33.17%, iM Life 29.51%, and Hana Life 14.26%. Among non-life insurers, Heungkuk Fire & Marine Insurance reported 47.6%, Hana Insurance 22.43%, and Lotte Insurance minus 5.4%.
For brokers, these figures are not abstract. Each of these six insurers is a potential counterparty, and a core capital ratio below zero or in the low double digits signals a carrier whose financial position depends on transitional regulatory relief rather than underlying strength.
Subordinated bond issuance by Korean insurers dropped from 3.9 trillion won in 2025 to 100 billion won in the first half of 2026, according to Korea Securities Depository data reported by the Seoul Economic Daily. That narrows the capital-raising options available to weaker carriers.
Seokjae Lee, senior financial analyst at AM Best, noted in a July 2026 market report that “some market leaders with stronger balance sheet capacity and solvency positions are looking beyond the domestic market.” That divergence between well-capitalised insurers expanding internationally and undercapitalised ones struggling to attract buyers or raise capital is creating a two-tier market that intermediaries need to monitor when assessing counterparty strength.
South Korea’s insurance sector has undergone rapid consolidation as a direct consequence of these capital pressures, a trend that is narrowing the field of available counterparties for brokers placing business in the Korean market.
The FSC announced in January 2026 that from 2027, insurers must hold core capital of at least 50% of required capital. Those falling below face prompt corrective action. A nine-year transition period runs through the end of 2035. As of Q3 2025, 16 of South Korea’s 38 insurers reported core capital ratios below 80%, according to a Fitch Ratings report that stated the new requirements “will enhance the quality of insurers’ capital” but noted the previous framework had encouraged reliance on non-permanent subordinated securities.
The shift is not unique to South Korea. Milliman’s 2026 report on life insurance capital regimes in Asia found that most markets across the region now follow some form of risk-based capital framework, with reforms increasingly aligned with the International Association of Insurance Supervisors’ Insurance Capital Standard and IFRS 17. For intermediaries operating across Asian markets, counterparty due diligence increasingly requires an understanding of how solvency ratios are calculated, what transitional relief is in effect, and how incoming rules will affect insurer capital positions over the medium term.
